Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
918 GBX | -0.54% | -6.13% | +2.68% |
Mar. 26 | Biotech Group Acquisition Withdraws IPO | DJ |
2023 | Biotech Growth's total return underperforms benchmark in tough market | AN |
Sales 2022 | -205M -261M | Sales 2023 | -32.42M -41.33M | Capitalization | 303M 387M |
---|---|---|---|---|---|
Net income 2022 | -202M -258M | Net income 2023 | -41M -52.28M | EV / Sales 2022 | -1.96 x |
Net Debt 2022 | 31.74M 40.47M | Net Debt 2023 | 17.4M 22.18M | EV / Sales 2023 | -9.89 x |
P/E ratio 2022 |
-1.84
x | P/E ratio 2023 |
-7.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.47% |
1 day | -0.33% | ||
1 week | -6.13% | ||
Current month | -3.77% | ||
1 month | -3.57% | ||
3 months | -7.37% | ||
6 months | +22.07% | ||
Current year | +2.68% |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Hsu
BRD | Director/Board Member | - | 18-05-15 |
Roger Yates
CHM | Chairman | 67 | 21-11-30 |
Steve Bates
BRD | Director/Board Member | 66 | 15-07-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 918 | -0.54% | 64 319 |
24-05-28 | 923 | -2.64% | 63,374 |
24-05-24 | 948 | -1.15% | 140,492 |
24-05-23 | 959 | -1.94% | 22,541 |
24-05-22 | 978 | -0.81% | 55,166 |
Delayed Quote London S.E., May 29, 2024 at 06:45 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+2.68% | 393M | |
+9.03% | 15.08B | |
+5.41% | 6.52B | |
+18.05% | 4.74B | |
+9.51% | 4.43B | |
-8.66% | 4.03B | |
+10.22% | 3.41B | |
-2.99% | 3.37B | |
+9.40% | 3.2B | |
-2.40% | 2.86B |
- Stock Market
- Equities
- BIOG Stock